Name: Payables Turnover

Definition: Payables turnover shows how fast the company pays its suppliers for goods or services bought on credit. A high turnover means the company pays suppliers quickly, which may reflect strong cash flow or favorable terms. A very low turnover might mean the company is stretching payments to preserve cash — or possibly experiencing financial strain.

Interpretation:
• In '2021', TNFA's payables turnover was 0.00, indicating how promptly the company pays its suppliers. Industry average for Biotechnology: In Vitro & In Vivo Diagnostic Substances in '2021' stood at 4.18.
• In '2022', TNFA's payables turnover was 0.00, indicating how promptly the company pays its suppliers. The figure remained stable compared to '2021'. Industry average for Biotechnology: In Vitro & In Vivo Diagnostic Substances in '2022' stood at 4.52. Industry average increased by 0.34 compared to previous year.
• In '2023', TNFA's payables turnover was 0.00, indicating how promptly the company pays its suppliers. The figure remained stable compared to '2022'. Industry average for Biotechnology: In Vitro & In Vivo Diagnostic Substances in '2023' stood at 4.33. Industry average declined by 0.19 from previous year.
• In '2024', TNFA's payables turnover was 0.00, indicating how promptly the company pays its suppliers. The figure remained stable compared to '2023'. Industry average for Biotechnology: In Vitro & In Vivo Diagnostic Substances in '2024' stood at 3.40. Industry average declined by 0.94 from previous year.
Overall, TNFA's payables turnover has remained generally stable over the past 4 years.

Formula: Payables Turnover = Cost of Goods Sold / Average Accounts Payable

Good Range: Ranges 5-15 depending on industry.